BBA
GNMX
Baker Bros. Advisors’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3,950,419
| Closed | -$2.77M | – | 100 |
|
|
2018
Q4 | $2.77M | Hold |
3,950,419
| – | – | 0.02% | 66 |
|
|
2018
Q3 | $4.86M | Sell |
3,950,419
-104,723
| -3% | -$129K | 0.03% | 71 |
|
|
2018
Q2 | $4.5M | Hold |
4,055,142
| – | – | 0.03% | 79 |
|
|
2018
Q1 | $8.15M | Hold |
4,055,142
| – | – | 0.07% | 65 |
|
|
2017
Q4 | $4.87M | Sell |
4,055,142
-491,284
| -11% | -$590K | 0.04% | 79 |
|
|
2017
Q3 | $5.73M | Buy |
4,546,426
+2,928,337
| +181% | +$3.69M | 0.05% | 73 |
|
|
2017
Q2 | $2.15M | Hold |
1,618,089
| – | – | 0.02% | 85 |
|
|
2017
Q1 | $3.01M | Buy |
1,618,089
+737,550
| +84% | +$1.37M | 0.02% | 79 |
|
|
2016
Q4 | $4.56M | Hold |
880,539
| – | – | 0.04% | 67 |
|
|
2016
Q3 | $4.91M | Hold |
880,539
| – | – | 0.04% | 71 |
|
|
2016
Q2 | $4.89M | Buy |
880,539
+115,539
| +15% | +$641K | 0.05% | 75 |
|
|
2016
Q1 | $3.37M | Hold |
765,000
| – | – | 0.04% | 83 |
|
|
2015
Q4 | $4.61M | Buy |
+765,000
| New | +$4.61M | 0.04% | 81 |
|